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Apoptosis, bioenergetics, and oxidative stress have been implicated in Amyotrophic 
Lateral Sclerosis (ALS) disease progression; it is unclear as to how the interactions within this 
highly inter-related triad of categories influences the time course of the disease or, how effective 
therapeutic modulation could be accomplished. In this multi-scale study, we aim to simulate the 
molecular responses in ALS and map the timing of the interactions between the response 
mechanisms in high-copy SOD1 G93A (superoxide dismutase-1, glycine 93 to alanine) 
transgenic mice in order to determine which parameters and relationships have the most 
significant impact on ALS in each stage of the pathology. In addition, the possibility of 
homeostatic instabilities within the triad prior to, during, and after ALS symptom onset is 
examined. We observed several apoptosis- and oxidative stress-related metrics which are 
elevated throughout ALS disease course, with evidence of early disturbances. We identify 
regulatory differences within the apoptosis-bioenergetics-oxidative stress triad between G93A 
and wild type mice that could contribute to homeostatic instability leading to ALS symptom 







Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized 
by the loss of motor neuron activities in the spinal cord, which leads to muscle paralysis, 
dysphagia, respiratory distress, and ultimately death. The causative mechanism of the disease has 
yet to be elucidated.   Less than 10% of ALS cases are considered to be familial; the 
overwhelming preponderance are considered “sporadic” with no definitive known cause. [1] 
Several theories have been proposed regarding the possible etiology, which have been tested to 
varying extents using different transgenic in vitro and in vivo mouse models. The transgenic 
superoxide dismutase 1 glycine 93 to alanine mutation (hereafter referred to as SOD1 G93A) 
represents one of the most commonly used mouse models to study ALS pathophysiology [2].  In 
fact, the Laboratory for Pathology Dynamics at Georgia Institute of Technology has transcribed 
data from over 3,800 peer-reviewed articles for the SOD1 G93A mouse model.   
Kim et. al, 2015 identifies multiple interrelated categorical disturbances contributing to 
ALS disease progression ranging from axonal transport to excitotoxicity. [3] Of these factors, 
apoptosis, bioenergetics, and oxidative stress have been identified as some of the key molecular 
mechanisms affecting ALS pathophysiology. In SOD1 G93A mice, mitochondrial respiration, 
specifically the electron transport chain, and ATP synthesis have been found to be impaired. [4] 
Furthermore, ATP has been implicated in neuromuscular junction (NMJ) damage through 
production of an inhibitory action on neurotransmitter release via reactive oxygen species (ROS) 
induction. [5] Oxidative stress is believed to increase the net production of ROS and reactive 
nitrogen species (RNS) and affect protein conformation and structure which can lead to the 
accumulation of abnormal protein inclusions. [6] In addition, several apoptotic factors have been 
implicated in ALS disease progression, such as the caspase family, notably in the pre-
symptomatic and end-stages of the disease. [7] 
Our lab has also previously developed the homeostatic instability theory, which states 
that several cellular or systemic perturbations have the ability to initiate a pathophysiological 
cascade resulting in homeostatic instability - the inability to maintain or restore homeostasis. [8-
10] In the framework of this theory, ALS systems’ inability to efficiently and effectively utilize 
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regulatory mechanisms to compensate for instabilities results in the “ALS” phenotype. 
 The present study investigates the interactions within the apoptosis - bioenergetics - 
oxidative stress triad and examines their effect on ALS disease progression. In particular, we 
examine the possibility of instabilities in the SOD1 G93A model manifesting throughout disease 
progression through application of experimental perturbations.  The hypothesis behind the 
present study is that system-level regulatory dysfunction could be driving ALS disease 
progression irrespective of the initiating causative perturbation.  In fact, motoneurons, in general, 
are known to be more susceptible to instability [11].  To this end, we compare the regulatory 
responses of SOD1 G93A ALS mice to wild type mice.  The long-term goal is to identify 
treatment targets that focus on re-establishing system stability, or homeostasis, after the clinical 
onset of ALS.  Such an approach best considers the multi-factorial nature of ALS and is more 
likely to lead to therapeutic strategies that could help a greater portion of the ALS population, 
albeit whether the initiating etiology is familial, sporadic, environmental, or somewhere in-
between. 
The study consists of two major thrusts:  1) Statistical assessment of aggregated in vitro 
and in vivo experimental data from the apoptosis - bioenergetics - oxidative stress triad to assess 
the SOD1 G93A regulatory response, including magnitude and directionality of responses 
compared to wild type mice; 2) Dynamic meta-analysis computer simulation to examine system 
dynamics of the SOD1 G93A mouse model and parameter optimization to search for potential 
treatment targets that could re-establish homeostasis in ALS, corresponding to life-prolonging 
interventions or possibly even a cure. 
The Methods utilized for both thrusts, including protocols for planned future work, is 
presented in Chapter 2.  The work of the first thrust was completed and the results of the 
statistical assessment of experimental data is presented in Chapter 3.  The second thrust, which 
included the construction of a multi-scalar dynamic meta-analysis computer simulation of both 
the SOD1 G93A and wild type mouse models, is a large undertaking that extends beyond the 
scope of the present thesis; Chapter 4 presents the results to date of the dynamic meta-analysis 
computer simulation as well as future plans to ultimately complete this portion of the work.  






MATERIALS AND METHODS 
2.1 Data Collection and Inclusion 
A literature review was performed to establish the scope of the study with particular 
focus on the triad of apoptosis, bioenergetics, and oxidative stress as the topics of interest. A set 
of keywords pertaining to these topics was compiled in order to assist in narrowing the data 
search.  A PubMed search resulted in approximately 2000 relevant experimental articles for data 
extraction. The data pool for the study was compiled by only including results that contained 
quantifiable data from both in vivo and in vitro studies; in the current study, in vivo and in vitro 
data are analyzed separately. In addition, papers containing control and treated data for SOD1 
G93A and wild-type mice were considered to ensure that the effects of different etiological 
perturbations could be quantified. Finally, treatments and experimentally assessed outcomes (i.e. 
referred to as “outputs”) in the data entries were only considered if they were direct measures of 
categories in the metrics list. The final data pool that satisfies all the inclusion criteria included 
more than 700 data points from 70 individual articles. 
2.2 Aggregation Scheme 
Collected data was assigned to a set of coordinates indicating a relationship, one 
coordinate for the perturbation and one coordinate for its measured effect. For relationships 
without sufficient numbers of data points to ensure statistical significance, an aggregation 
scheme was developed to pool similar metrics together; metrics were grouped based on their 
pathophysiological functionality.  
a) Apoptosis: All parameters directly relating to or leading to programmed cell death were 
listed under this category. Furthermore, metrics measuring necrotic cell death, 
unspecified cell death, and cell viability are also listed under this category. 
The outputs in this category were: 
(1) Pro-apoptotic factors: caspases, cytochrome C release, etc. 
(2) Anti-apoptotic factors: Bcl-2, zVAD-fmk, etc. 
(3) Cell Death: both necrotic and apoptotic cell death 
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(4) Cell Viability 
b) Oxidative Stress: All parameters relating to the production of free radicals and 
antioxidants. 
The outputs for this category were: 
(1) SOD1 levels: SOD1 enzymatic activity, function 
(2) Pro-oxidative stress factors: free radicals, ROS, etc. 
(3) Antioxidants: glutathione levels, free radical scavengers, etc. 
(4) Oxidative stress damage: oxidative damage to protein, lipids and DNA 
c) Bioenergetics: All parameters relating to different cellular processes that harvest and 
transform energy such as cellular respiration and other metabolic processes that lead to 
the production and utilization of energy. 
This category’s outputs were:  
(1) Energy consumption: oxygen consumption, ATP levels, glucose levels, etc. 
(2) Energy production: activities of complexes in the electron transport chain, ADP 
levels, etc. 
2.3 Direct Statistical Analysis of Aggregated Experimental Data 
The fold changes of the experimentally assessed outcome metric in SOD1 G93A mice 
and WT mice were recorded and expressed as a normalized metric for each study or study 
aggregate using the ratio of the SOD1 G93A / WT. Comparisons included observations of the 
ratio of untreated transgenic and wild type mice (untreated SOD1 G93A / untreated wild type) as 
well as observations of the responses of treated transgenic and wild type mice (treated SOD1 
G93A response / treated wild type response).  “Treated” (i.e. perturbed) transgenic and wild type 
mice were used to assess possible differences in the rate of regulatory response in SOD1 G93A 
mice compared to wild type regulatory response. The resulting ratios were plotted versus time to 
examine the magnitude, directionality and rate of change in response to treated (i.e. perturbed) 
parameters.  Observations were made both across the lifetime of the mice (in vivo) or the 
experimental time (in vitro).  In the case of temporally binned data (when applicable), data 
samples were equally distributed.  
Without making parametric assumptions about the collected data, linear regression was 
performed on the raw ratios to determine overall trends. Some linear regression lines were found 
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to have an imperfect fit due to the variations in data, and thus smooth curves were generated 
using locally weighted regression on Igor Pro. In addition, the ratios of the SOD1 G93A gain to 
the WT gain are expressed as mean ± standard deviation.  The Shapiro-Wilks test was used to 
determine the experimental data distribution, which was found to exhibit a non-normal 
distribution pattern.  As such, the Kruskal-Wallis test was chosen as the primary statistical 
assessment due to its known superiority in statistically assessing a non-normal distribution.  
Significant differences in the magnitude of the responses to different perturbations were assessed 
using a Kruskal-Wallis analysis of variance followed by a multiple comparison test.  A p-value 
of less than 0.05 was considered to be statistically significant. In addition, a principal component 
analysis (PCA) was performed on the transformed individual metric data to determine which 
metrics were responsible for producing the largest variance. All statistical tests were conducted 
using MATLAB R2014a software.  
 
2.4 Computer Model Simulation with Dynamic Meta-Analysis 
 Our lab previously developed a mathematical modeling method called dynamic meta-
analysis (DMA) to simulate temporal changes and dynamics of progression of multi-factorial 
pathologies, including ALS. [7] Unlike traditional meta-analysis, which requires a “static” 
assumption (i.e. does not include time), dynamic meta-analysis predicts responses of the outputs 
of interest to different perturbations over time by incorporating time-varying interactions 
between parameters.  The model consists of a list of initial values for the parameters being 
simulated and a gain matrix both of which are discussed in detail in the following sub-sections. 
The output of the dynamic meta-analysis function for the present study is the values (i.e. ratios of 
perturbed responses over control responses) of each parameter over a specified time.  We utilize 
maximum lifespan of the SOD1 G93A mouse (200 days for in vivo and 100 days for in vitro) for 




 Equation 1. 
In equation 1, n is each time step in days. At n=1, [Outputs]n-1 is equal to a vector of initial 
values for all the parameters. Due to different life spans of in vivo and in vitro experimental 
models, in vitro data were run separately from in vivo data, with the same amount of time steps 
performed for each parameter.  
2.4.1 Construction of the computational model gain matrix 
As part of the calculation shown in Equation 1, DMA utilizes a gain matrix, which contains the 
average daily gain for every simulated parameter.  The gain is analogous to a feedback gain in 
engineering control theory, which specifies how the rate and magnitude of change associated 
with one output will impact the response of a related output.  In order to capture the gain for each 
output, the gain was calculated from the raw experimentally measured ratio of treated over 
control at discrete experimentally measured points of time.  Gains at discrete experimentally 
measured time points are transformed into a continuous function which calculates the gain at 
each day of the in vivo or in vitro experimental model lifespan.  Where applicable, the average of 
the time-vary gains for each categorical parameter (e.g. caspase, cytochrome c, etc.) is used to 
determine the aggregate time-varying gain for the category (e.g. pro-apoptosis).  The ratio in 
Equation 2 represents the ratio of the SOD1 G93A gain to the WT gain (SOD1 G93A gain / WT 
gain). 
 
Equation 2.  𝐺𝑎𝑖𝑛 = 𝑎𝑣𝑒𝑟𝑎𝑔𝑒( √𝑟𝑎𝑡𝑖𝑜
𝑑𝑎𝑦𝑠
) 
2.4.2 Optimizing parameters to construct a stable or “homeostatic” wild type mouse model 
 Due to the lack of published data for certain relationships, the gain matrices of both 
SOD1 G93A and wild-type mouse models contain empty values. Without these values, neither 
the SOD1 G93A or wild type model emulates expected regulation.  In particular, it is assumed 
that the outputs of the wild type mouse should be stable over time, due to its ability to 
compensate for transient perturbations and ultimately maintain homeostasis.  Without a 
homeostatic wild type mouse model, regulatory changes in the SOD1 G93A mouse cannot be 
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fully evaluated.  Thus, we utilize a search-survey-summarize approach [9] to find appropriate 
values to insert into the empty gain matrix cells, which should theoretically provide the 
regulatory feedback needed to enable wild type mouse homeostasis (i.e. output stability over the 
normal life span of the wild type mouse). 
 In this study, a genetic algorithm from Matlab’s global optimization toolbox was used to 
optimize the empty values in the wild-type gain matrix. Compared to other search methods such 
as Simplex search, genetic algorithms have the advantage of generating a large amount of 
solution sets across all regions using “parent seeds”.  Thus, is does not require an acutely 
accurate initial guess, which would otherwise be difficult to determine due to lack of 
corresponding experimental assessments in the physiological literature.   
 Genetic algorithm parameter optimization was utilized to find missing gain values that 
result in wild type mouse outcome stability upon reaching steady state.  To assess the stability of 
each of the optimized gain matrices generated from the genetic algorithm, eigenvalues were 
calculated using Matlab. If all the eigenvalues have real parts that are negative, the steady state 
of the system is considered to be stable. In addition, if an eigenvalue has a real part that equals 
zero and is not complex, it is considered the same as having a negative real part (i.e. it is a stable 
solution).  For any other permutations of eigenvalues, the system is considered to be unstable at 
steady state.   As a starting point, 1,000 degenerate solution sets were generated by the genetic 
algorithm.   
 The degenerate solution sets were quantitatively and qualitatively evaluated to determine 
which of the parameter ranges could be physiologically relevant in the wild type mouse.  
Parameter sensitivity analyses (e.g. altering an individual parameter by a set percentage and re-
running the model to assess effect) of both optimized parameters and initial start values of the 
outputs were used to quantify impact.  Other analyses include visualization of the relationships 
among optimized parameter sets and corresponding outputs using cross-correlation analysis, box 
plots, and standard heuristic or pattern-determining assessments (e.g. time constant of steady 
state, amplitude of highest non-steady state peak, etc.).  Where possible, experimental literature 
was used to determine possible boundaries of optimized parameter ranges or initial output start 
values.  Finally, the simulated temporal outputs (or outcomes) corresponding to the identified 
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potentially physiologically relevant parameter solution sets were compared to known 
physiological outcomes at discrete time points with data not used to construct the model.  
2.4.3 Protocol for constructing SOD1 G93A computational model with full gain matrix 
The SOD1 G93A gain matrix is missing the same empty gain matrix values as the wild type.  
Therefore, once the missing values from the wild type gain matrix have been determined, they 
were directly inserted into the SOD1 G93A gain matrix.  Unlike the wild type mouse, we cannot 
assume that the SOD1 G93A mouse is stable, especially post-onset.  Thus, with the presently 
existing experimental data, there is no way to truly “optimize” the SOD1 G93A equivalent of the 
optimized wild type missing values.  However, the insertion of the optimized missing wild type 
values into the base SOD1 G93A model allows a direct comparison of the differences between 
the known experimentally measured gain values and their impact on the corresponding SOD1 
G93A system regulation and model outputs.  Moreover, reverse engineering of SOD1 G93A 
stability (after ALS onset) through optimizing either the missing gain values or the known 
experimentally determined gains provides the equivalent of theoretical ALS treatments.  The 
same genetic algorithm as used for optimizing the wild type model can be utilized to reverse 
engineer ALS post-onset stability in the SOD1 G93A ALS model by searching for the gain 
modifications needed to establish post-onset stability.   Modified gains necessary to re-establish 









STATISTICAL COMPARISON OF EXPERIMENTALLY ASSESSED 
REGULATORY RESPONSE IN SOD1 G93A ALS AND WILD TYPE MICE 
 
3.1 Apoptosis, Bioenergetics, and Oxidative Stress are Highly Interrelated. 
Figure 1 presents densely connected relationship maps for the in vitro and in vivo models. 
In total, 21 relationships were identified in vitro and 20 relationships were observed in vivo. 
Qualitative examination of the relationships illustrates that metrics belonging to apoptosis, 
bioenergetics, and oxidative stress are highly interrelated. Notably, the majority of the 
relationships were between apoptosis- and oxidative stress-related metrics. Given the sheer 
number of relationships observed involving oxidative stress- and apoptosis-related metrics, these 
categories appear to be more interactively contributing to ALS disease progression than 
bioenergetics-related metrics. 
 
3.2 Elevated Levels of Apoptosis- and Oxidative Stress-related Parameters Observed in 
SOD1 G93A Mouse Model. 
 Several studies have found links between elevated oxidative stress levels and ALS as a 
result of factors such as protein carbonyls, 3-nitrotyrosine, and oxidative damage, which have 
been found in increasing levels in various tissues in ALS cases. [12] Through examination of the 
time-averaged control in vivo ratios, cell death levels were highest, followed by pro-oxidative 
stress factors, oxidative stress damages, SOD1, anti- and pro-apoptotic factors, and antioxidants. 
In particular, metrics pertaining to apoptosis or oxidative stress were present in higher levels, on 
average, throughout the disease course in SOD1 G93A mice. Interestingly, anti- and pro-
apoptotic factor levels were the same, as well as energy production and consumption levels, 








Figure 1. Relationship maps for aggregated metrics (A) in vivo and (B) in vitro indicate that 
the parameters within the apoptosis-bioenergetics-oxidative stress triad are highly 
interrelated. Relationships between parameters were identified and then classified based on the 
metrics table. The metric at the beginning of the arrow is defined as the perturbation and the 
metric at the arrowhead is defined to be the response. A positive correlation refers to when there 
is an increase in the response with respect to time; a negative correlation is observed when there 
is a respective decrease in the response. Most of the relationships observed are between 
aggregated metrics in the oxidative stress and apoptosis categories and more relationships were 
observed in vitro than in vivo. A. Oxidative stress-related metrics are primarily responsible for 
eliciting different responses in metrics. SOD1 G93A and WT mice respond in different ways to 
perturbations respond in opposite ways to perturbations from primarily oxidative stress-related 
metrics. Pro-oxidative stress factors caused a decrease in cell viability in SOD1 G93A mice, but 
no change in WT mice. Perturbations from antioxidants led to opposite trends observed in energy 
production, SOD1, oxidative stress damage, pro-oxidative stress, and cell viability levels in 
SOD1 G93A and WT mice. B. Similar to in vivo, oxidative stress-related metrics produce a 
variety of responses for metrics in SOD1 G93A and WT mice. Opposite responses were 
observed in SOD1 G93A and WT mice, primarily in response to antioxidants. 
 
 The results from the in vitro studies exhibit similar trends to the in vivo results, with pro-
apoptotic factors, cell death, and oxidative stress damages having the highest levels. Similarly, 
these observations suggest that apoptosis- and oxidative stress-related metrics are present in 
larger amounts in SOD1 G93A mice than WT mice. Cell death levels remained elevated, 
however, and unlike the in vivo study, pro- and anti-apoptotic factors were not present in the 
same amounts.  This finding implicates a major difference between the regulatory dynamics in in 
vitro and in vivo SOD1 G93A ALS models, which will ultimately need to be reconciled. 
 Levels of pro-oxidative stress factors, such as hydroxyl radicals, have been found to be 
greater in SOD1 G93A mice than in WT mice. [13] Examination of the temporal trends in the in 
vivo model revealed that cell death, oxidative stress damage, and pro-oxidative stress factors 
were elevated in SOD1 G93A mice at multiple points throughout disease progression. In 
addition, metrics classified under the oxidative stress category were elevated between 50 and 100 
days in the in vivo model, encompassing pre-onset and onset of ALS (80 days). [11] Specifically, 
pro-oxidative stress values increased between 0-50 and 50-100 days, but plateaued beyond 100 
days. Oxidative stress damage levels steadily increased during each time bin. These trends 
suggest that oxidative stress could be affecting disease progression as early as in the pre-onset 
stage and levels continue to remain high throughout the course of the disease. 
 While the time-averaged results suggested that overall, pro-apoptotic factor levels were 
higher in SOD1 G93A mice, they actually decreased between 50-100 and post 100 days in vivo. 
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In addition, cell death levels were elevated between 0-50 days and post 100 days. Given the 
greater levels of cell death, the decrease in pro-apoptotic factors could suggest that cell death 
may not have been induced through apoptotic pathways, but rather through other forms of cell 
death such as necrosis. 
 The in vitro model displays similar trends in that apoptosis- and oxidative stress-related 
metrics were also elevated throughout the disease course of SOD1 G93A mice. Apoptosis levels 
in SOD1 G93A mice were higher than WT levels throughout disease progression; metric levels 
peak between 1 and 2 days, and then decrease. Oxidative stress metric levels are considerably 
lower than apoptosis-related metrics. Once again, comparison of the specific trends observed 
conflict with those observed in the in vivo model. In vitro cell death in SOD1 G93A mice, while 
still elevated above WT levels, decreased with each successive time step. Trends in pro-apoptotic 
factors in the in vitro model, however, were consistent with those observed in the in vivo model 
in that pro-apoptotic factors decreased with time. 
3.3 Temporal Trends in Apoptosis, Bioenergetics, and Oxidative Stress-related Parameters 
Decrease Over Time in SOD1 G93A Mouse Model. 
SOD1 G93A in vitro levels of antioxidant, cell viability, and energy production relative 
to WT decreased with time. (Fig. 3A) Evaluation of the levels of these metrics reveals that SOD1 
G93A antioxidant levels were initially greater than WT levels and both SOD1 G93A energy 
production and cell viability levels were lower than WT levels. These physiological occurrences 
suggest that not only does the disease affect how SOD1 G93A mice are able to respond to 
perturbations or changes to their physiology, as exemplified by the decrease in cell viability and 
energy production, but also suggests that initial levels of these factors are pre-emptively different 
in SOD1 G93A mice compared to WT mice.  Thus, the SOD1 G93A ALS mice have some de 
facto differences in their physiology that are present at birth, well before the onset of functionally 
visible ALS symptoms. 
In SOD1 G93A mice, reductions in mitochondrial respiration have been found to be 
linked to oxidative stress in the spinal cord. [14] The results indicate that SOD1 G93A in vivo 
levels of pro-apoptotic and energy production levels decreased with respect to WT mice, but 
oxidative stress damage levels increased. (Fig. 3B) The in vivo trend in energy production is 
consistent with the trend observed in vitro. Furthermore, trends in pro-apoptotic factors and 
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oxidative stress damage were consistent with the results obtained in Figure 2 as they decreased 
and increased, respectively, with time. 
 
Figure 2. Time-averaged and time-binned physiological parameter values reveal that 
primarily apoptosis- and oxidative stress-related metrics are elevated at various points in 
disease course in SOD1 G93A mice. SOD1 G93A control data were normalized to their 
corresponding WT control data. A. Control ratios for SOD1 G93A and WT mice show elevated 
levels of apoptosis- and oxidative stress-related metrics both in vivo (i) and in vitro (ii). (i). Pro- 
and anti-apoptotic factor levels, as well as energy production and energy consumption levels, 
have similar levels. Cell death has the highest observed value. (ii). Pro-apoptotic factor and cell 
death levels are elevated, as well as oxidative stress damage levels. B. Fold changes in 
aggregated physiological metrics over time in in vivo (i) and in vitro (ii) models. Control ratios 
organized into different time bins revealed specific trends in the aggregated metrics. (i) 
Oxidative stress damage, pro-oxidative stress, and cell death levels are elevated at various stages 
throughout disease progression, and energy production and pro-apoptotic factor levels decrease 
during disease progression. (ii) Apoptosis-related metrics are present in larger amounts 







3.4 SOD1 G93A and Wild-type Mouse Model Elicit Markedly Different Responses to 
Perturbation.  
A common theme emerging in this analysis is the notable differences between the SOD1 
G93A and WT’s physiological responses to perturbations, specifically the pronounced reactions 
from the SOD1 G93A mouse. These responses from each mouse type can be classified by their 
directionality (e.g. same or opposite directional response) and their response magnitude (e.g. 
larger or smaller absolute response). In addition, evidence of oscillatory behavior in response to 
perturbation was observed in both WT and SOD1 G93A mice, with SOD1 G93A responses 
having larger peak oscillation amplitudes. 
A relationship of particular interest was observed between oxidative stress damage and 
cell viability in vitro where the SOD1 G93A and WT systems produced opposite reactions in 
response to the perturbation. (Fig. 4Ai) Cell viability in the SOD1 G93A in vitro system 
considerably increased with the presence of oxidative stress damage, whereas cell viability in the 
WT system minimally decreased. Examination of the slopes of each line indicates that the slope 
of the SOD1 G93A response is 90 times the slope of the WT response. This observation is in 
contradiction with literature results as oxidative stress damage has been found to decrease cell 
viability.  
In many cases, the SOD1 G93A mouse responds more dramatically to perturbations than 
the WT mouse, producing a greater magnitude of change in its response. Oxidative stress 
damage caused an increase in antioxidant levels in both SOD1 G93A and WT mice in vitro, 
however, the magnitude of change in the SOD1 G93A response was almost three times higher 
than WT response. (Fig. 4Aii) In addition, large oscillations were observed early on in the 
disease course suggesting that the SOD1 G93A system is particularly sensitive to oxidative stress 
damage. It is also important to note that initial antioxidant levels in the SOD1 G93A system were 
already elevated above WT levels, indicating that there are initial differences between the two 
mouse types at the cellular level even prior to full ALS onset. The application of antioxidants to 
both the SOD1 G93A and WT systems in vivo led to an overall decrease in oxidative stress 
damage despite an initial spike following the perturbation. (Fig. 4Bi) The change in oxidative 
stress damage levels was five times as great in SOD1 G93A mice as it was in WT mice. In 
addition, application of antioxidants led to initial fluctuations in levels of SOD1 G93A cell 
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viability and an overall decrease in cell viability in vitro (Fig. 4Bii). Overall, the WT physiology 
was largely unaffected by the increase in antioxidant levels and exhibited oscillations with small 
amplitudes. These results suggest that the SOD1 G93A physiology is more sensitive to 
antioxidant perturbations, which results in large oscillations.  In contrast, the WT physiology is 
robust and can ultimately re-stabilize to internal or external perturbations. 
The combination of these observations indicates that the SOD1 G93A system is 
responding more aggressively to perturbations and could point to underlying instabilities in the 
regulatory mechanisms. Furthermore, the nature of the WT responses suggest that the system is 
generally unaffected by perturbations.  Thus, the WT system could be utilizing compensatory 
mechanisms that are either simply not present or perhaps dysfunctional in the SOD1 G93A 
system. 
3.5 Cell Viability of SOD1 G93A Mouse Model Significantly Affected by Apoptosis-and 
Oxidative Stress-related Perturbation in vitro. 
 After performing a Kruskal-Wallis test using p < 0.05 and p < 0.01 to identify 
quantitative statistical significance, no significant results were observed in vivo. However, 
qualitatively, antioxidants produced the greatest increase and pro-oxidative stress factors the 
greatest decrease in SOD1 G93A cell viability, respectively. 
Comparison of the effects of perturbations from apoptosis- and oxidative stress-related 
factors led to the most noteworthy results in vitro. Pro-apoptotic factors produced twice as large 
of a fold change in SOD1 G93A cell viability than pro-oxidative stress factors (Fig. 5A). Further 
analysis of the fold changes revealed that pro-apoptotic factors increased cell viability in the 
SOD1 G93A in vitro model whereas pro-oxidative stress factors actually decreased cell viability 
in SOD1 G93A in vitro model. Based on the SOD1 G93A responses to each of these 
corresponding perturbations, pro-oxidative stress factors negatively impacted in vitro SOD1 
G93A cell viability whereas pro-apoptotic factors improved in vitro SOD1 G93A cell viability.  
Moreover, perturbations resulting from antioxidants significantly increased in vitro SOD1 G93A 
cell viability by approximately 1.5 times more than pro-oxidative stress factors (Fig. 5A). The 
marked increase in in vitro SOD1 G93A cell viability upon application of antioxidants could be 
indicative of an antioxidant deficiency in the in vitro SOD1 G93A experimental mouse model.  
Finally, oxidative stress damage led to a fold change of approximately 1.6 times more in in vitro 
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SOD1 G93A cell viability than pro-oxidative stress factors. (Fig. 5A) Since oxidative stress 
damage is caused by pro-oxidative stress factors, it is possible that oxidative stress damage did 
not have the ability to further “propagate”; thus, the damage to SOD1 G93A cell viability was 
capped due to the collinearity between pro-oxidative stress factors and oxidative stress damage. 
3.6 Contributions of Observed Data Variance in vitro and in vivo. 
Principal component analysis (PCA) illustrates which variable contributions are primarily 
contributing to outcome variance.  We performed PCA on the aggregated, in vitro, and in vivo 
data sets.  In both SOD1 G93A and WT in vitro responses, caspase-8 was the primary factor 
contributing to the variance observed (Fig. 6A, B). Caspase-8 is a protein involved in apoptosis 
induced by Fas and other apoptotic stimuli [15]. Specifically, caspase-8 is activated by death 
receptors, such as Fas and p75, which in turn activates executioner caspases using both direct 
and indirect methods through Bid. In WT mice, copper (an antioxidant as well as a key 
enzymatic catalyst) was the second-most important contributor to the variance in the data 
whereas, in SOD1 G93A mice, the pro-oxidative stress factors, iNOS and nNOS, were the 
second-most important contributor to variance. In both WT and SOD1 G93A in vivo responses, 
other antioxidants primarily contributed to the variance observed in the data  (Fig. 6C-D) 
Ultimately, these results suggest that apoptosis- and oxidative stress related metrics account the 
most for variance in both in vitro and in vivo WT and SOD1 G93A data, and conversely, 















DYNAMIC META-ANALYSIS COMPUTER SIMULATION OF SYSTEM 
REGULATION IN SOD1 G93A ALS AND WILD TYPE MICE  
 
4.1 Construction of Dynamic Meta-Analysis Models 
 Dynamic meta-analysis computer models were successfully constructed in Matlab using 
the methods described in Chapter 2.  Figure 1 and Table 1 illustrates the connectivity and 
relationships, respectively, used to construct the models.  Architecture was created to simulate in 
vitro wild type, in vitro SOD1 G93A, in vivo wild type, and in vivo SOD1 G93A mouse models.  
A matrix was established to house the gains utilized for each respective model type.  The 2-D 
matrix for each model type has rows and columns of the same length, enabling a potential 
relationship between every assessed category.  However, a relationship to fill every cell in the 
matrix was not always available or able to be calculated from the experimental literature.  An 
initial simulation of the in vivo wild type model using only the available experimentally obtained 
gains illustrated the need for additional [experimentally unavailable] gains in order to obtain 
steady-state system stability, or homeostasis, in the in vivo wild type mouse model.  To this end, 
a genetic algorithm was used to identify the “missing” gain values in the 2-D matrix using 
eigenvalue steady-state stability criteria as described in Chapter 2.  Optimization was repeated 
for both the in vitro and in vivo wild type models.  Given the size and scope of the dynamic 
meta-analysis computational model project, the present thesis focuses on wild type mouse model 
construction and results while providing a protocol and underlying programming architecture for 









Table 1. In vivo data count. 
 
 Data Points Ratios Papers 
B-B 36 18 4 
B-A 0 0 0 
B-O 0 0 0 
A-A 36 18 6 
A-B 0 0 0 
A-O 0 0 0 
O-B 36 18 4 
O-A 40 20 8 
O-O 56 28 10 
A 62 31 - 
B 60 30 - 
O 50 25 - 
Overall 204 102 23 
A = apoptosis, B = bioenergetics, O = oxidative stress. 
 
Table 2. In vitro data count. 
 
 Data Points Ratios Papers 
B-B 2 1 1 
B-A 14 7 4 
B-O 6 3 1 
A-A 106 53 13 
A-B 8 4 2 
A-O 18 9 5 
O-B 6 3 2 
O-A 270 135 28 
O-O 78 39 13 
A 310 155 - 
B 16 8 - 
O 142 71 - 
Overall 508 254 47 







 The genetic algorithm generated 1,000 new gain matrices for both in vitro and in vivo 
wild-type model. In Figure 3, the changes of each parameters were plotted using the original gain 
matrix. Most of the parameters are diverging over the lifespan of the mouse (200 days). 
However, using a gain matrix generated from the genetic algorithm, all parameters were able to 
reach a steady state, as shown in Figure 4. From a quick analysis of the trends and shapes of the 
of the plots from the 1,000 simulations of the genetic algorithm, no specific patterns have been 
identified at the time of this writing.  Continued analysis is in progress to differentiate parameter 
values with their corresponding solutions using a variety of qualitative and quantitative analyses 
as presented the Methods of Chapter 2. 
 
4.2 Genetic Algorithms Generates Distinctive Solution Sets for Wild Type mouse 
 
 
Figure 3. Simulation of wild-type mouse model without optimization. Parameters diverge 




Figure 4. Simulation of wild-type mouse model using optimized gains matrix. System 
responds to perturbations and drives all parameters to an equilibrium. 
 
4.3 Gain Matrices from Genetic Algorithms Reveals High Degree of Degeneracy 
  To analyze any similarities among the generated wild-type in vitro gain matrices, a 
boxplot, shown in Figure 5, was generated to show the span of each altered value. The plot 
illustrates a wide range of stable solution parameter values for almost all parameters, indicating 
that the stability or homeostasis of the wild-type system can be dependent on various distinctly 
different sets of parameter values. Thus, there is a high degree of degeneracy in the wild-type 
system with multiple pathways able to produce the same emergent property of homeostasis. The 
degree of degeneracy in the wild type mouse also hints that homeostatic instabilities in ALS 
could likely be caused by numerous individual or combinations of different factors.  The boxplot 
indicates there is a substantial degree of stabilizing negative feedback terms (or gains), all of 
which belong to parameters of energy production, oxidative damage, pro-oxidative stress factors, 
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and cell viability. Since cell viability primarily serves as an output in our mathematical model, 
this result indicates that regulating energy production and oxidative stress levels are key to 
bringing wild-type mouse model back to steady state when the system experiences a 
perturbation.  The latter result is particularly interesting given that, in the aggregated 
experimental data statistical assessment presented in Chapter 3, PCA reveals that bioenergetics 
accounted for the least amount of variance in the system.  Likewise, energetics terms in the 
computational system had a narrower range of parameter values corresponding to stable system 
solutions.  Collectively these results indicate a lesser degree of degeneracy with bioenergetics.   
The lesser degree of degeneracy with bioenergetics is likely tied to the lower number of inter-
relationships between bioenergetics and other included metrics.  It remains to be seen whether 
the present degeneracy or lesser inter-relatedness of bioenergetics will remain once additional 
categories of metrics are added (e.g. excitability, axonal transport, proteomics, etc.)  On the other 
hand, the lesser degeneracy with bioenergetics could also be tied to the fact that measures of 
bioenergetics (e.g. ATP, respiration, etc.) are inherently lower in the SOD1 G93A ALS mice 
from birth, as presented in the previous chapter. 
 
 
Figure 5. Boxplot of gains values from 1000 runs of genetic algorithm. Negative feedbacks 
are present in relationships 1, 7, 22, 37, 46, and 63, which all belongs to categories of energy 




4.4 Cross Correlation between Parameters of Wild-type Mouse Model in vitro and in vivo 
  Sensitivity analysis with a 10-50% increase in each parameter were performed and the 
output’s cross correlation with original outputs are calculated and the averages are shown in 
Table 3. Cell viability shows the least correlation to other parameters, which is a reasonable 
result because viability is often considered as an output or response in our model instead of a 
treatment or perturbation.  In the biological system, cell viability could also be considered an 
emergent property.  Inconsistency in in vitro and in vivo was seen in energy production, where it 
is highly correlated to other parameters in vitro and not in vivo. Oxidative stress damage has 
shown high correlation to other parameters both in vitro and in vivo. This high correlation may 
suggest that oxidative stress damage is a redundant parameter in the model. In fact, oxidative 
stress damage has a very similar classification as pro-oxidative stress factors.  However, 
redundancy, like degeneracy, is expected and biological systems.  Continued cross-correlation 
analysis, combined with heuristic assessments, will be applied as we seek to justify parameter 
values with physiological ramifications. 
Table 3. Average cross correlation from outputs of DMA model using 1000 gains matrices 
generated by genetic algorithm. Values highlighted in green indicate relative high correlation, 







4.5 Future Directions 
 The eventual goal of this study is to formulate a model that best describes the 
relationships among the factors involved in ALS pathophysiology. The current analysis on the 
wild-type gain matrices from genetic algorithm surely provides some insights on the underlying 
molecular mechanisms of ALS, but finding a specific wild-type gain matrix is necessary for 
further study on these mechanisms. Therefore, the next step of this project will be analyzing the 
current wild type gain matrices generated by the genetic algorithm, and identifying similarities 
among the matrices that can be supported by adjunctive physiological literature. Statistical 
analysis will be performed to set upper and lower limits for particular gains, thus narrowing the 
range of the potential physiologically relevant parameter values. Once a specific wild-type 
matrix is determined to be the best fit, simulations will be run that combine the experimentally 
determined SOD1 G93A gains with the overlapping “missing” gains optimized in the wild-type 
model. The simulation with SOD1 G93A data can be used as a tool to compare and contrast the 
effects of known differences in regulatory gains in the SOD1 G93A and wild type mice.   Also, 
reverse engineering (as outlined in the Chapter 2 Methods) using genetic algorithm optimization 
can be used to search for possible treatments for ALS by identifying parameters (or gains) that 
can re-stabilize the SOD1 G93A system after the onset of visible ALS symptoms.  
 While the current models focus on the bioenergetics-oxidative stress-apoptosis triad, we 
plan to expand the model connectivity to include other pathophysiological categories known to 
contribute to ALS, such as axonal transport, inflammation, excitability, and proteomics.  The 
aforementioned categories not currently included have functional endpoints that directly connect 
to the bioenergetics-oxidative stress-apoptosis triad.   Thus, at present, the effects of these 
categories are implicitly included in the optimized “missing” gains analogous to a “blackbox” 
model contribution.  Over-parameterization is a major concern in multi-scalar models.  Thus, 
maintaining focus on the bioenergetics-oxidative stress-apoptosis triad, where the functional 
outcomes of ALS most directly result, was one way to initially avoid over-parameterization at 








The present study identifies the relationships present within the apoptosis-bioenergetics-
oxidative stress triad and reveals that the three categories are highly interrelated. The complexity 
of the interactions within the triad are underscored by the sheer number of relationships 
identified in Figure 1. There are many interacting variables in the G93A system, which in turn 
makes it difficult to isolate a single category, or factor, that can be implicated in ALS disease 
progression. It appears as if a combination of factors may be responsible, or minimally, a 
combination of factors may be required to treat ALS. Of the three categories studied, apoptosis 
and oxidative stress were more densely connected.  Thus, their strong interactions suggest the 
possibility of exploiting synergistic relationships to treat mechanisms contributing to ALS 
progression. Several studies have implicated oxidative stress in inducing apoptotic cell death by 
triggering apoptotic pathways in the cell [12].  Specifically, oxidative stress damages, which 
cause injury to cellular components, trigger cell death [16].  While Bioenergetics does not have 
as strong of connections or as numerous interactions, the fact that bioenergetics is decreased 
throughout the lifespan of SOD1 G93A ALS mice (as illustrated in the Chapter 3 results), 
indicates it is an early precipitator of ALS progression.  The narrower parameter ranges 
identified in the optimization of the wild type mouse dynamic meta-analysis computer model 
suggests there are less degenerate or redundant pathways to compensate for the effect of 
bioenergetics in maintaining homeostatic stability. 
We hypothesize that the general principles behind system regulation could explain how a 
variety of different perturbation or initiating cellular events could evolve into the phenotype we 
see and know as ALS. The future ability to further assess and compare the system dynamics of 
SOD1 G93A ALS and wild type mouse through computer simulation will enable an assessment 
to determine what factors or feedback responses work sequentially, simultaneously, or a 
combination to produce the observed pathological system instability observed in SOD1 G93A 
mice. The nature of the interactions identified in the statistical analysis of aggregated 
experimental data as well as the dynamic meta-analysis computer simulations only reinforce that 
ALS is a complex, multifactorial disease. 
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5.1 Sensitivity of SOD1 G93A Mouse Model to Apoptosis- and Oxidative Stress-driven 
Changes to the System. 
 In Figures 2, 7, and 8, oxidative stress-related metrics were observed to be elevated 
during multiple time intervals throughout disease progression. Oxidative stress damages can lead 
to imbalances in ROS production and removal, which in turn causes ROS accumulation and can 
further exacerbate disease progression. [17] The increased presence of pro-oxidative stress 
factors and oxidative stress damage observed, especially in the early stages of the disease, 
suggest that the SOD1 G93A model is particularly sensitive to perturbation of these metrics. In 
literature, evidence of elevated oxidative stress factor levels prior to and at disease onset, has 
been found, which supports the findings of the present analysis. [18] Moreover, early signs of 
oxidative stress have been observed in all major neurodegenerative diseases, suggesting a 
common neuropathological continuum and perhaps even the possibility of shared therapeutic 
targets [19-21].  
 In addition, the SOD1 G93A model appears to be particularly sensitive to antioxidants. 
Multi-layer antioxidant networks are present in mitochondria to counteract oxidative stress 
damage, including internally produced oxidants of respiration as well as external exposure [22]. 
Deficiencies to the oxidative and anti-oxidative dynamic balance, for instance proteins (such as 
MnSOD) losing antioxidant function, can cause mitochondria to lose the ability to sufficiently 
compensate for oxidative stress damage. [22] Figure 6Aii highlights that SOD1 G93A control 
antioxidant levels decrease over time, suggesting that the SOD1 G93A model loses the capability 
to produce sufficient levels of compensatory antioxidants. Moreover, Figures 7Bi and 8A 
indicate that the addition of antioxidants decreases oxidative stress damage levels and increases 
cell viability in SOD1 G93A mice respectively, which is consistent with literature findings. [21] 
Figure 6Ai appears to contradict the present study’s findings, as it suggests that treating SOD1 
G93A mice with antioxidants actually decreases cell viability in vivo. One possible explanation 
for the previous observation could be that the SOD1 G93A model is utilizing a combination of 
mechanisms to compensate for the changes to the system and the addition of antioxidants leads 
to an excess in compensatory factors which ultimately has an adverse effect on cell viability. 
Alternatively, application of the antioxidant treatment could cause the SOD1 G93A model to 
overcompensate, which could partially destabilize the SOD1 G93A model.  Both the 
experimental and computational results of this work do suggest that there is hyper-regulation or 
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overly aggressive responses to perturbation in the SOD1 G93A mouse model.  Though meant to 
be helpful, it could be that the application of high levels of anti-oxidants in combination to the 
overly zealous SOD1 G93A regulatory response actually shifts the dynamic balance too far, from 
one of the spectrum to the other, resulting in harmful cell viability outcomes.   Further 
investigation needs to be conducted to definitively elucidate the effect of antioxidants on disease 
progression.   It appears the usage of anti-oxidants would have to be carefully tailored to the 
specific nature of temporal disease progression. 
 Furthermore, apoptosis-related metrics were observed to be elevated during various 
stages of disease progression. Apoptotic pathways trigger cell death, and removal of them has 
been associated with increased cell viability, motor function, and lifespan in familial ALS 
models. [19] Imbalances between pro-and anti-apoptotic factors in SOD1 G93A mice, which are 
elevated with respect to levels in WT mice, can be observed throughout disease progression both 
in vitro and in vivo. Cell death levels are also elevated. In regards to members of the Bcl-2 
family, such as Bim, Bad, and Bax (all pro-apoptotic factors) and Bcl-2 (an anti-apoptotic 
factor), there is evidence that the ratio of anti- to pro-apoptotic factors influences the viability of 
developing and mature cells; considerable differences in levels of either factor can lead to 
activation of caspase-related apoptosis through release of cytochrome c into the cytosol. [23] In 
Figure 8A however, pro-apoptotic factor perturbations in fact increase SOD1 G93A cell 
viability, which is in direct contrast to literature findings. It is possible that the increase in pro-
apoptotic factors could be inducing greater levels of death amongst unhealthy cells and thus 
preventing pre-existing damage, for instance from oxidative stress, from further propagating and 
decreasing healthy cell viability. Thus, the increase in pro-apoptotic factors could actually be a 
protective mechanism to prevent the “spread” of ALS.  Again, the ability to dynamically balance 
pro- and anti-apoptotic factors is crucial.   A recurring theme of the present work is that the 
SOD1 G93A mouse exhibits dynamic imbalances that complexly, rather than intuitively, 
influence the outcomes of the disease and its experimental markers.   Dynamic imbalances point 
towards the need for carefully timed and titrated combination therapies to restore system-level 
homeostasis after the clinical onset of ALS symptoms. 
Further analysis of the effect of apoptosis- and oxidative stress-related metrics on disease 
progression using PCA points to caspase-8, copper, iNOS/nNOS, other antioxidants, and other 
oxidative stress as major contributors to the trends observed. Specifically, the SOD1 G93A 
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model may be increasingly susceptible or over-active to perturbations relating to the 
bioenergetics-apoptosis-oxidative stress triad. For instance, literature findings suggest that SOD1 
G93A motor neurons exhibit increased sensitivity to activation of the nitric oxide pathway 
downstream of Fas. [24] While cell death levels in SOD1 G93A and WT mice were comparable, 
SOD1 G93A produced more exaggerated cell death response even when perturbed with 
intermediate levels of Fas activation; as a result, the SOD1 G93A model was more sensitive to 
perturbations and an overexpression of WT SOD1 conferred protection against Fas-induced cell 
death. [24]  Also, it should be noted that the experimentally observed levels of cell death in 
SOD1 G93A mice are likely under-represented since, as the disease progresses, there are simply 
less cells remaining in the SOD1 G93A mice compared to wild type.  Therefore, at later stages of 
ALS, it may appear as if motoneuron cell death is a less of a factor when in reality most of the 














Figure 6. Temporal trends reveal that several SOD1 G93A metric levels decrease relative to 
WT levels over time. SOD1 G93A control data were normalized to their corresponding WT 
control data. A. Antioxidant, cell viability, and energy production levels all decrease with time in 
vitro. In SOD1 G93A mice, cell viability (iii) and energy production (ii) levels are initially 
depressed in comparison to WT levels, but antioxidant (i) levels are initially elevated. B. Pro-
apoptotic factors (i) and energy production (ii) levels decrease with time and oxidative stress 
damage (iii) levels increase with time in vivo. In SOD1 G93A mice, pro-apoptotic factor and 
energy production levels are elevated in comparison to WT levels, but oxidative stress damage 














Figure 7. Temporal trends SOD1 G93A and WT treatment data reveal more dramatic 
oscillatory behavior in SOD1 G93A mice in response to perturbations than WT mice. SOD1 
G93A treated data were normalized to their corresponding WT treated data. A. In vitro 
physiological responses. (i) SOD1 G93A and WT mice had opposite cell viability responses 
when perturbed with oxidative stress damage; SOD1 G93A cell viability levels increased, while 
WT cell viability levels decreased. (ii) Antioxidant levels increased in response to perturbations 
from oxidative stress damage in both SOD1 G93A and WT mice. SOD1 G93A antioxidant levels 
were considerably higher than WT antioxidant levels. B. In vivo physiological responses. 
Oxidative stress damage levels decreased, overall, in both SOD1 G93A and WT mice when 
perturbed with antioxidants; SOD1 G93A oxidative stress damage levels were lower than WT 
oxidative stress damage levels. Linear regression was performed data to obtain the directionality 
of the overall trend of the data, and a LOESS curve fitting was used to identify the specific 

























Figure 8. Perturbations to both SOD1 G93A and WT systems show significant changes in 
vitro. SOD1 G93A responses were normalized to WT responses in order to determine the fold 
change in response to the different perturbations belonging to the three broad categories of 
apoptosis, bioenergetics, and oxidative stress. Relationships with fold changes greater than one 
indicate that the SOD1 G93A system responds more dramatically to perturbations to the system 
than the WT system. (A) Fold changes in the SOD1 G93A responses to different perturbations in 
vitro. Most of the significant fold changes observed were between metrics belonging to apoptosis 
and oxidative stress. (B) Fold changes in the SOD1 G93A responses to different perturbations in 
vivo. No significant relationships were observed amongst metrics. Kruskal-Wallis and multi 























Figure 9. Principal component analysis (PCA) of individual metrics in G93A and WT mice. 
PCA analysis performed on the datasets containing metrics influencing disease progression for 
both WT and SOD1 G93A in vitro and in vivo data. Scree plots for each mouse type and 
projection of metrics onto first and second principal components were created. A. WT in vitro 
data. Scree plot indicates that principal component 1, correlated most strongly with caspase-8 
levels, accounted for 35.1% of the variance and principal component 2, correlated most strongly 
with copper levels, accounted for 20.7% of the variance. B. SOD1 G93A in vitro data. Scree plot 
indicates that principal component 1, correlated most strongly with caspase-8 levels, accounted 
for 27.1% of the variance and principal component 2, correlated most strongly with iNOS/nNOS 
levels, accounted for 24.0% of the variance. C. WT in vivo data. Scree plot indicates that 
principal component 1, correlated most strongly with other antioxidant levels, accounted for 
65.3% of the variance and principal component 2, correlated most strongly with other oxidative 
stress levels, accounted for 31.0% of the variance. D. SOD1 G93A in vivo data. Scree plot 
indicates that principal component 1, correlated most strongly with other antioxidant levels, 
almost exclusively accounted for the variance observed (99.0%). 
 
 
5.2 Regulatory Mechanisms in SOD1 G93A and Wild-type Mice: A Comparison 
 Throughout the analysis, we have discovered that the SOD1 G93A system responses to 
perturbations are inherently different from WT system responses. Perturbations from each of the 
categories to the WT system produce physiological responses, which initially deviate slightly 
from the pre-perturbation state, but eventually return to the initial and expected homeostatic 
state; moreover, the WT system has been shown to respond in a similar manner to perturbations 
throughout its lifespan. The WT system is able to effectively respond to perturbations because its 
regulatory mechanisms are able to efficiently compensate for perturbations without 
overzealously reacting, which would otherwise induce continuous oscillatory instability (akin to 
an engineered control system with a too-high gain). Ultimately, these regulatory mechanisms 
confer stability to the WT model, which provides adequate resistance to any harmful changes to 
the system. 
In direct contrast to the WT model, the SOD1 G93A model has been shown in this 
analysis to respond more aggressively, with evidence of higher amplitude and more frequent 
fluctuations following perturbation. These observations are exemplified by the difference in 
magnitude and fold changes of the SOD1 G93A responses to perturbations, especially apoptosis- 
and oxidative stress-related ones. The SOD1 G93A behavior observed when the system is 
perturbed provides evidence in support of a phenomenon called “hypervigilant regulation.” It can 
be characterized as a tendency for regulatory mechanisms to correct disturbances to homeostasis 
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through exaggerated responses. [10, 11] Initially, the aggressive nature of the SOD1 G93A 
responses may not be detrimental to the viability of the system. However, over time, the repeated 
strain placed on the regulatory mechanisms to compensate for perturbations is believed to 
destabilize the system and contribute to the ALS phenotype. [9, 10]  In short, the SOD1 G93A 
mouse model is akin to an engineered control system with a too-high gain.   With small 
perturbations early in life, the SOD1 G93A mouse’s overzealous control is not detrimental to its 
life or motor function.  However, a larger single perturbation or multiple smaller perturbations 
puts the system at risk for disastrous instability, initiating the true “onset” of ALS and ultimately 
resulting in the propagation and spread of motoneuron death.  Hypervigilant regulation could 
explain why clinical ALS patients tend be “healthier” than the normal population early in their 
life; their over-zealous physiology aggressively corrects small imbalances that would otherwise 
result in diseases like hyperlipidemia, diabetes, or hypertension.  Instead, as larger or cumulative 
perturbations are sustained later in life, the overzealous regulatory physiology cannot maintain 
homeostasis.  Given motoneurons are inherently more susceptible to instability, they succumb to 
the disease and phenotype we see and know as ALS. [10, 11] 
 
5.3 Role of Bioenergetics-Apoptosis-Oxidative Stress Triad in ALS System Instability. 
 Given the sensitivity of the SOD1 G93A model to apoptosis- and oxidative stress-related 
perturbations, and the resulting changes to the system in response to them, the broader categories 
of apoptosis and oxidative stress appear to play instrumental roles in ALS disease progression 
induced by synergistic and degenerate interaction. This conclusion is further confirmed by the 
results of the PCA analysis pinpointing caspase-8 and various oxidative stress metrics as being 
primary contributors to variance in the data. In addition, the study’s findings suggest that 
apoptosis and oxidative stress contribute more to disease progression than bioenergetics. 
However, it is important to recognize that the bioenergetics data pool is considerably smaller 
than the apoptosis and oxidative stress data pools because fewer studies have been performed on 
bioenergetics-related metrics in relation to ALS. As a result, the effect of bioenergetics could be 
under-represented in both its magnitude of effect and degree of interaction.  However, the 
experimental data does show that bioenergetics is consistently depressed in SOD1 G93A mice 
from birth, well before the onset of symptoms.  The narrower range of bioenergetics parameters 
corresponding to stable steady-state solutions in the wild type mouse reveal that there is less 
41 
 
degeneracy and redundancy in the bioenergetics category.  Therefore, it is more difficult for 
bioenergetics to compensate for perturbation even in the wild type mouse model.  It appears the 
implicit impact of bioenergetics could be much greater on overall regulation and system stability, 
even if at the experimental single-metric level, it appears to be less directly tied to cell death then 
oxidative stress and apoptotic pathways.  Moreover, both the statistical assessment of 
experimental data and the present computer models indicate that perturbations in the oxidative 
stress pathway initiate a death-spiral cascade in the SOD1 G93A mosue that precludes the 
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